CEFUROXIME-INDUCED THROMBOCYTOPENIA: IT'S JUST NOT IN THE RING??
Beta lactams are one of the most commonly used antibiotic groups in clinical practice, owing to their relatively superior safety profile, when weighed against other available antibiotics. Cephalosporins have overgrown over the years, now extending across five generations of drugs. Older cephalosporins are still commonly used, chiefly because of their low cost and minimal adverse effects. However, no drug is entirely free of adverse effects. Cephalosporins (especially those with a methylthiotetrazole ring) have been associated with bleeding manifestations due to hypoprothrombinemia and thrombocytopenia in susceptible subsets of the global population. This case report concerns the use of a cephalosporin that does not have this ring in its structure, but has still caused a rare instance of thrombocytopenia
Keywords: Beta lactam, Cefuroxime, Platelets, Bleeding, Methylthiotetrazole.
2. Pathak A, Kunder SK, Avinash A, Patil N, Rao NK. A rare case of tamoxifen-induced thrombocytopenia. J App Pharm Sci 2016;6(1):156-7.
3. Aitken P, Zaidi SM. Cefuroxime-induced thrombocytopenia? Postgrad Med J 1996;72(854):757-8.
4. Gauer RL, Braun MM. Thrombocytopenia. Am Fam Physician 2012;85(6):612-22.
5. van den Bemt PM, Meyboom RH, Egberts AC. Drug-induced immune thrombocytopenia. Drug Saf 2004;27(15):1243-52.
6. Kenney B, Stack G. Drug-induced thrombocytopenia. Arch Pathol Lab Med 2009;133(2):309-14.
7. Aster RH. Drug-induced immune cytopenias. Toxicology 2005;209(2):149-53.
8. Kalman D, Barriere SL. Review of the pharmacology, pharmacokinetics, and clinical use of cephalosporins. Tex Heart Inst J 1990;17(3):203-15.
9. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30(2):239-45.
10. Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49(9):2229-32.
11. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992;27(6):538.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.